Heimo Strohmaier
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
Papers in
-
- Lipid metabolism and biosynthesis 2
- Co-authors
- Charles SpruckSteven I. ReedOlle SangfeltKwang‐Ai WonPeter KaiserChristian GuellyMartin StradnerMichael Trauner
- Journals
- Journal of Bacteriology (2 papers)Clinical and Experimental Rheumatology (1 paper)Journal of Leukocyte Biology (1 paper)Frontiers in Immunology (1 paper)Journal of Neuroinflammation (1 paper)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Heimo Strohmaier
32 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 781
- Molecular Biology 1.9k
- Cell Biology 415
- Oncology 686
- Biochemistry 80
Countries citing papers authored by Heimo Strohmaier
This map shows the geographic impact of Heimo Strohmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heimo Strohmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heimo Strohmaier more than expected).
Fields of papers citing papers by Heimo Strohmaier
This network shows the impact of papers produced by Heimo Strohmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heimo Strohmaier. The network helps show where Heimo Strohmaier may publish in the future.
Co-authors
The 25 scholars most cited alongside Heimo Strohmaier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 50 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 102 | |
| 7 | 2019 | 23 | |
| 8 | 2018 | 77 | |
| 9 | 2018 | 3 | |
| 10 | 2018 | 26 | |
| 11 | 2014 | 18 | |
| 12 | 2012 | 18 | |
| 13 | 2010 | 95 | |
| 14 | 2010 | 99 | |
| 15 | Characterization of HULC, a Novel Gene With Striking Up-Regulation in Hepatocellular Carcinoma, as Noncoding RNA Hit paper breakdown → | 2006 | 665 |
| 16 | 2001 | 491 | |
| 17 | 2001 | 318 | |
| 18 | 1999 | 25 | |
| 19 | 1998 | 45 | |
| 20 | 1995 | 83 |
About Heimo Strohmaier
Heimo Strohmaier is a scholar working on Biochemistry, Molecular Medicine, Biological Psychiatry, Dermatology and Infectious Diseases, having authored 33 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Antifungal resistance and susceptibility (5 papers), Systemic Sclerosis and Related Diseases (5 papers), Fungal Infections and Studies (4 papers), DNA Repair Mechanisms (3 papers), Bacterial Genetics and Biotechnology (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Cancer Research (781 citations), Molecular Biology (1.9k citations), Cell Biology (415 citations), Oncology (686 citations) and Biochemistry (80 citations). Heimo Strohmaier has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Charles Spruck, Steven I. Reed, Olle Sangfelt, Kwang‐Ai Won, Peter Kaiser, Christian Guelly, Martin Stradner, Michael Trauner, Charles R. Buck and Kurt Zatloukal. Their work appears in journals such as Journal of Bacteriology, Clinical and Experimental Rheumatology, Journal of Leukocyte Biology, Frontiers in Immunology and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.